JBCHEPHARM.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally...

Stats
本日の出来高	465 731
平均出来高	157 519
時価総額	279.12B
EPS	INR0 ( 2024-02-07 )
次の収益日	( INR0 ) 2024-05-21
Last Dividend	INR9.25 ( 2023-08-16 )
Next Dividend	INR0 ( N/A )
P/E	55.12
ATR14	INR2.06 (0.12%)

ボリューム相関

長: -0.10 (neutral)

短: -0.32 (neutral)

Signal:(28.503) Neutral

J. B. Chemicals & 相関

10 最も正の相関
ASIANHOTNR.NS	0.803

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

J. B. Chemicals & 相関 - 通貨/商品

-0.37
( neutral )

-0.28
( neutral )

0.06
( neutral )

-0.45
( neutral )

-0.60
( weak negative )

-0.26
( neutral )

J. B. Chemicals & 財務諸表

Annual	2022
収益:	INR31.49B
総利益:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
収益:	INR31.49B
総利益:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
収益:	INR24.24B
総利益:	INR15.61B (64.39 %)
EPS:	INR49.86

FY	2021
収益:	INR20.06B
総利益:	INR12.88B (64.23 %)
EPS:	INR57.96

Financial Reports:

No articles found.

J. B. Chemicals & Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR8.00 (N/A)	INR0 (N/A)	INR8.50 (N/A)	INR0 (N/A)	INR9.25 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

J. B. Chemicals & Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.86 - low (61.49%) | Divividend Growth Potential Score: 5.37 - Stable (7.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.600	2003-06-30
Last Dividend	INR9.25	2023-08-16
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR149.65	--
Avg. Dividend % Per Year	1.66%	--
Score	3.52	--
Div. Sustainability Score	4.86
Div.Growth Potential Score	5.37
Div. Directional Score	5.12	--

Next Divdend (Est)
(2024-12-10)

INR9.67 Estimate 6.79 %

Dividend Stability

0.27 Very Poor

Dividend Score

3.52

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.00	0.62%
2019	INR5.00	3.21%
2020	INR12.00	5.59%
2021	INR16.50	3.19%
2022	INR16.50	1.89%
2023	INR17.75	1.80%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SBIN.NS	Dividend Junior	2023-05-31	Sporadic	29	0.99%
MAHSEAMLES.NS	Dividend Junior	2023-08-14	Annually	21	0.80%
GODFRYPHLP.NS	Dividend Junior	2023-08-11	Annually	24	1.52%
AURIONPRO.NS	Dividend Junior	2023-09-22	Sporadic	19	0.36%
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PGIL.NS	Dividend Junior	2023-09-01	Annually	17	1.08%
JINDALSAW.NS	Dividend Junior	2023-06-13	Annually	22	1.62%
DEEPAKNTR.NS	Dividend Junior	2023-07-27	Annually	14	0.25%
SKMEGGPROD.NS	Dividend Junior	2023-08-30	Sporadic	21	0.95%
MGEL.NS	Dividend Junior	2023-08-08	Annually	5	0.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.198	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	59.22	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	14.16	2.00	2.92	5.84	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.890	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.855	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.86

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	54.78	1.000	4.57	0	[1 - 100]
returnOnEquityTTM	0.198	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	14.16	2.00	5.28	5.84	[0 - 30]
dividendYielPercentageTTM	0.557	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	8.70	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0648	1.000	-0.879	0	[0.1 - 0.5]
Total Score				5.37

J. B. Chemicals &

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.